Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIND Therapeutics Inc (NASDAQ:BIND)

1.36
Delayed Data
As of 4:00pm ET
 -0.02 / -1.45%
Today’s Change
1.30
Today|||52-Week Range
8.10
-40.61%
Year-to-Date
No recent news for BIND Therapeutics Inc.

Today’s Trading

Previous close1.38
Today’s open1.37
Day’s range1.30 - 1.40
Volume68,433
Average volume (3 months)97,646
Market cap$28.7M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-1.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-4.36%
P/E ratioNM
Price/Sales8.54
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
KDUSCadus Corp-0.03-2.75%
CANFCan Fite Biopharma L...-0.04-1.96%
XTNTXtant Medical Holdin...0.000.00%
BNTCBenitec Biopharma Lt...0.000.00%
Data as of 4:02pm ET, 02/09/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$10.4M
Annual profit (last year)-$32.5M
Net profit margin-312.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew J. Hirsch
Secretary, Treasurer, SVP-Finance &
Administration
Christopher M. Lindblom
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers